Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA.
Department of Psychology, University of Arizona, Tucson, AZ, USA.
J Psychosoc Oncol. 2023;41(1):59-75. doi: 10.1080/07347332.2022.2033377. Epub 2022 Feb 6.
Few psychosocial interventions have been tailored to meet the unique needs of patients diagnosed with lung cancer. This pilot study developed and tested a six-week intervention for reducing lung cancer stigma. Guided by qualitative interviews conducted with 9 lung cancer patients and 5 thoracic oncology care providers, Acceptance and Commitment Therapy was adapted for treatment of lung cancer stigma (ACT-LCS). In a subsequent single arm pilot study, 22 lung cancer patients reporting high levels of stigma completed the intervention. NCI-designated cancer centers in the Southwestern and Eastern United States. Of 46 eligible patients, 22 provided consent, with 20 completing the intervention (10 in-person, 10 telehealth). Overall stigma decreased across timepoints, largely driven by reductions in internalized stigma. There were also significant reductions in social isolation, sleep disturbance, and fatigue. The ACT-LCS protocol demonstrates preliminary feasibility and acceptability. This intervention may be particularly suited for helping patients navigate feelings associated with internalized stigma.
很少有心理社会干预措施是专门针对满足肺癌患者独特需求而设计的。本试点研究开发并测试了一项为期六周的干预措施，以减少肺癌耻辱感。该干预措施以与 9 名肺癌患者和 5 名胸肿瘤学护理提供者进行的定性访谈为指导，接受和承诺疗法被改编用于治疗肺癌耻辱感（ACT-LCS）。在随后的一项单臂试点研究中，22 名报告高度肺癌耻辱感的患者完成了该干预措施。美国西南部和东部的 NCI 指定癌症中心。在 46 名符合条件的患者中，有 22 名患者同意参加，其中 20 名完成了干预措施（10 名面对面，10 名远程医疗）。总体耻辱感随着时间的推移而降低，主要是由于内化耻辱感的降低。社交孤立、睡眠障碍和疲劳也有显著减少。ACT-LCS 方案初步显示出可行性和可接受性。该干预措施可能特别适合帮助患者应对与内化耻辱感相关的情绪。
